Clinical Trials

NCT02593994 | ACTIVE_NOT_RECRUITING
4500 participants

IRIS-Onyx Cohort in the IRIS-DES Registry

Study Type:
OBSERVATIONAL
Last Updated:
2026-06-24
Start Date:
2015-10-31
Completion:
2027-12-31
Conditions
  • Coronary Artery Disease
  • Arterial Occlusive Diseases
  • Cardiovascular Diseases
  • Percutaneous Transluminal Angioplasty
Interventions
  • DEVICE
No Results Yet
NCT02581514 | COMPLETED | NA
53 participants

Eosinophilia Diagnosis

Study Type:
INTERVENTIONAL
Last Updated:
2026-06-24
Start Date:
2015-10-31
Completion:
2019-09-30
Conditions
  • Hypereosinophilic Syndrome
Interventions
  • OTHER
No Results Yet
NCT02332980 | COMPLETED | PHASE2
65 participants

Pembrolizumab Alone or With Idelalisib or Ibrutinib in Treating Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia or Other Low-Grade B-Cell Non-Hodgkin Lymphomas

Study Type:
INTERVENTIONAL
Last Updated:
2026-06-24
Start Date:
2015-02-19
Completion:
2021-08-10
Conditions
  • Recurrent B-Cell Non-Hodgkin Lymphoma
  • Recurrent Chronic Lymphocytic Leukemia
  • Recurrent Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue
  • Recurrent Grade 1 Follicular Lymphoma
  • Recurrent Grade 2 Follicular Lymphoma
  • Recurrent Grade 3 Follicular Lymphoma
  • Recurrent Lymphoplasmacytic Lymphoma
  • Recurrent Marginal Zone Lymphoma
  • Recurrent Nodal Marginal Zone Lymphoma
  • Recurrent Small Lymphocytic Lymphoma
  • Recurrent Splenic Marginal Zone Lymphoma
  • Recurrent Waldenstrom Macroglobulinemia
  • Refractory B-Cell Non-Hodgkin Lymphoma
  • Refractory Chronic Lymphocytic Leukemia
  • Refractory Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue
  • Refractory Follicular Lymphoma
  • Refractory Lymphoplasmacytic Lymphoma
  • Refractory Nodal Marginal Zone Lymphoma
  • Refractory Small Lymphocytic Lymphoma
  • Refractory Splenic Marginal Zone Lymphoma
  • Refractory Waldenstrom Macroglobulinemia
  • Richter Syndrome
  • Waldenstrom Macroglobulinemia
Interventions
  • DRUG
  • OTHER
  • BIOLOGICAL
NCT01989572 | COMPLETED | PHASE3
815 participants

Sargramostim, Vaccine Therapy, or Sargramostim and Vaccine Therapy in Preventing Disease Recurrence in Patients With Melanoma That Has Been Removed By Surgery

Study Type:
INTERVENTIONAL
Last Updated:
2026-06-24
Start Date:
2000-02-23
Completion:
2012-10-08
Conditions
  • Iris Melanoma
  • Medium/Large Size Posterior Uveal Melanoma
  • Mucosal Melanoma
  • Ocular Melanoma With Extraocular Extension
  • Recurrent Melanoma
  • Recurrent Uveal Melanoma
  • Small Size Posterior Uveal Melanoma
  • Stage IIA Cutaneous Melanoma AJCC v6 and v7
  • Stage IIA Uveal Melanoma AJCC v7
  • Stage IIB Cutaneous Melanoma AJCC v6 and v7
  • Stage IIB Uveal Melanoma AJCC v7
  • Stage IIC Cutaneous Melanoma AJCC v6 and v7
  • Stage IIIA Cutaneous Melanoma AJCC v7
  • Stage IIIA Uveal Melanoma AJCC v7
  • Stage IIIB Cutaneous Melanoma AJCC v7
  • Stage IIIB Uveal Melanoma AJCC v7
  • Stage IIIC Cutaneous Melanoma AJCC v7
  • Stage IIIC Uveal Melanoma AJCC v7
  • Stage IV Cutaneous Melanoma AJCC v6 and v7
  • Stage IV Uveal Melanoma AJCC v7
Interventions
  • OTHER
  • BIOLOGICAL
NCT01715402 | COMPLETED
3000 participants

Optimization of Health Expenditure in Liver Surgery

Study Type:
OBSERVATIONAL
Last Updated:
2026-06-24
Start Date:
2012-09-30
Completion:
2015-09-30
Conditions
  • Hepatocellular Carcinoma
  • Hilar Cholangiocarcinoma
  • Intra Hepatic Cholangiocarcinoma
  • Liver Metastasis
Interventions
  • PROCEDURE
No Results Yet
NCT01015833 | COMPLETED | PHASE3
356 participants

Sorafenib Tosylate With or Without Doxorubicin Hydrochloride in Treating Patients With Locally Advanced or Metastatic Liver Cancer

Study Type:
INTERVENTIONAL
Last Updated:
2026-06-24
Start Date:
2010-02-15
Completion:
2015-05-21
Conditions
  • Advanced Adult Hepatocellular Carcinoma
  • Recurrent Hepatocellular Carcinoma
  • Stage III Hepatocellular Carcinoma AJCC v7
  • Stage IIIA Hepatocellular Carcinoma AJCC v7
  • Stage IIIB Hepatocellular Carcinoma AJCC v7
  • Stage IIIC Hepatocellular Carcinoma AJCC v7
  • Stage IV Hepatocellular Carcinoma AJCC v7
  • Stage IVA Hepatocellular Carcinoma AJCC v7
  • Stage IVB Hepatocellular Carcinoma AJCC v7
  • Unresectable Hepatocellular Carcinoma
Interventions
  • DRUG
  • OTHER
NCT01012297 | TERMINATED | PHASE3
107 participants

Gemcitabine Hydrochloride and Docetaxel With or Without Bevacizumab in Treating Patients With Advanced or Recurrent Uterine Leiomyosarcoma

Study Type:
INTERVENTIONAL
Last Updated:
2026-06-24
Start Date:
2009-11-30
Completion:
2015-09-30
Conditions
  • Recurrent Uterine Corpus Sarcoma
  • Stage IIIA Uterine Sarcoma
  • Stage IIIB Uterine Sarcoma
  • Stage IIIC Uterine Sarcoma
  • Stage IVA Uterine Sarcoma
  • Stage IVB Uterine Sarcoma
  • Uterine Corpus Leiomyosarcoma
Interventions
  • BIOLOGICAL
  • DRUG
  • OTHER
NCT00942331 | COMPLETED | PHASE3
506 participants

Gemcitabine Hydrochloride and Cisplatin With or Without Bevacizumab in Treating Patients With Advanced Urinary Tract Cancer

Study Type:
INTERVENTIONAL
Last Updated:
2026-06-24
Start Date:
2009-07-15
Completion:
2018-11-02
Conditions
  • Advanced Urothelial Carcinoma
  • Metastatic Bladder Urothelial Carcinoma
  • Metastatic Prostate Carcinoma
  • Metastatic Renal Pelvis Urothelial Carcinoma
  • Metastatic Ureter Urothelial Carcinoma
  • Metastatic Urethral Urothelial Carcinoma
  • Metastatic Urothelial Carcinoma
  • Stage IV Bladder Urothelial Carcinoma AJCC v7
  • Stage IV Prostate Cancer AJCC v7
  • Stage IV Renal Pelvis Cancer AJCC v7
  • Stage IV Ureter Cancer AJCC v7
  • Stage IV Urethral Cancer AJCC v7
  • Unresectable Urothelial Carcinoma
Interventions
  • DRUG
  • OTHER
  • BIOLOGICAL
Previous
Sorted by latest updates
Next
Showing 40 trials per page